Traditional weight loss approaches fail because lupus undermines the fundamental assumptions behind them, that the body will respond normally to calorie restriction and exercise
The same dual action GLP-1 and GIP mechanism behind injectable tirzepatide, delivered as a daily oral tablet, a needle-free pill form alternative to the weekly injection
When this system becomes disrupted through gut dysbiosis, inflammation, or insulin resistance the coordination of appetite control, fat storage, and glucose regulation begins to falter
Zepbound is a registered trademark of Eli Lilly and Company
This is a journey you dont have to navigate alone
GLP-1 RAs offer new opportunities to manage T2DM, while also adding additional value in reducing the burden of obesity and overweight, as well as preventing cardiovascular disease